Stay updated on 12-Week Psoriasis Dose-Ranging Clinical Trial
Sign up to get notified when there's something new on the 12-Week Psoriasis Dose-Ranging Clinical Trial page.

Latest updates to the 12-Week Psoriasis Dose-Ranging Clinical Trial page
- Check7 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe site footer’s revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now shows a 403 error, replacing the study record content with an access-denied screen, effectively making the study details unavailable at this time.SummaryDifference18%

- Check55 days agoChange DetectedThe page revision metadata was updated to v3.6.6, replacing the prior v3.6.5.SummaryDifference0.1%

- Check69 days agoChange DetectedExpanded study details and metadata were added, including the From PubMed publications, investigator and center information, and expanded study plan sections. These additions provide more context on the trial design, affiliations, and references.SummaryDifference47%

- Check77 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5 on the page, indicating a refreshed version of the page content without altering the study details.SummaryDifference0.1%

Stay in the know with updates to 12-Week Psoriasis Dose-Ranging Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 12-Week Psoriasis Dose-Ranging Clinical Trial page.